▶ 調査レポート

世界の特殊医薬品市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Specialty Pharmaceuticals Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の特殊医薬品市場規模・現状・予測(2021年-2027年) / Global Specialty Pharmaceuticals Market Size, Status and Forecast 2021-2027 / QYR2104Z5389資料のイメージです。• レポートコード:QYR2104Z5389
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品、ヘルスケア
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、特殊医薬品のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(経口医薬品、非経口医薬品、経皮吸収型医薬品)、用途別市場規模(病院、小売薬局、専門薬局、通信販売)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・特殊医薬品の市場動向
・企業の競争状況、市場シェア
・特殊医薬品の種類別市場規模(経口医薬品、非経口医薬品、経皮吸収型医薬品)
・特殊医薬品の用途別市場規模(病院、小売薬局、専門薬局、通信販売)
・特殊医薬品の北米市場規模2016-2027(アメリカ、カナダ)
・特殊医薬品のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・特殊医薬品のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・特殊医薬品の中南米市場規模2016-2027(メキシコ、ブラジル)
・特殊医薬品の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Teva Pharmaceuticals、Abbvie、Amgen、Johnson & Johnson、Celgene、Gilead Sciences、Roche)
・結論

Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs.
North America accounts the significant market share due to high buying power and reimbursement for the specialty pharmaceuticals are the major factors boosting the growth of this market during the forecast period.

Market Analysis and Insights: Global Specialty Pharmaceuticals Market
The global Specialty Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Specialty Pharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Specialty Pharmaceuticals market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Specialty Pharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Specialty Pharmaceuticals market.

Global Specialty Pharmaceuticals Scope and Market Size
Specialty Pharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Pharmaceuticals
Parenteral Pharmaceuticals
Transdermal Pharmaceuticals

Segment by Application
Hospitals
Retail Pharmacies
Specialty Pharmacies
Mail Order

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva Pharmaceuticals
Abbvie
Amgen
Johnson & Johnson
Celgene
Gilead Sciences
Roche

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Pharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Pharmaceuticals
1.2.3 Parenteral Pharmaceuticals
1.2.4 Transdermal Pharmaceuticals
1.3 Market by Application
1.3.1 Global Specialty Pharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Retail Pharmacies
1.3.4 Specialty Pharmacies
1.3.5 Mail Order
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Specialty Pharmaceuticals Market Perspective (2016-2027)
2.2 Specialty Pharmaceuticals Growth Trends by Regions
2.2.1 Specialty Pharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Specialty Pharmaceuticals Historic Market Share by Regions (2016-2021)
2.2.3 Specialty Pharmaceuticals Forecasted Market Size by Regions (2022-2027)
2.3 Specialty Pharmaceuticals Industry Dynamic
2.3.1 Specialty Pharmaceuticals Market Trends
2.3.2 Specialty Pharmaceuticals Market Drivers
2.3.3 Specialty Pharmaceuticals Market Challenges
2.3.4 Specialty Pharmaceuticals Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Specialty Pharmaceuticals Players by Revenue
3.1.1 Global Top Specialty Pharmaceuticals Players by Revenue (2016-2021)
3.1.2 Global Specialty Pharmaceuticals Revenue Market Share by Players (2016-2021)
3.2 Global Specialty Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Specialty Pharmaceuticals Revenue
3.4 Global Specialty Pharmaceuticals Market Concentration Ratio
3.4.1 Global Specialty Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Pharmaceuticals Revenue in 2020
3.5 Specialty Pharmaceuticals Key Players Head office and Area Served
3.6 Key Players Specialty Pharmaceuticals Product Solution and Service
3.7 Date of Enter into Specialty Pharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Specialty Pharmaceuticals Breakdown Data by Type
4.1 Global Specialty Pharmaceuticals Historic Market Size by Type (2016-2021)
4.2 Global Specialty Pharmaceuticals Forecasted Market Size by Type (2022-2027)

5 Specialty Pharmaceuticals Breakdown Data by Application
5.1 Global Specialty Pharmaceuticals Historic Market Size by Application (2016-2021)
5.2 Global Specialty Pharmaceuticals Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Specialty Pharmaceuticals Market Size (2016-2027)
6.2 North America Specialty Pharmaceuticals Market Size by Type
6.2.1 North America Specialty Pharmaceuticals Market Size by Type (2016-2021)
6.2.2 North America Specialty Pharmaceuticals Market Size by Type (2022-2027)
6.2.3 North America Specialty Pharmaceuticals Market Size by Type (2016-2027)
6.3 North America Specialty Pharmaceuticals Market Size by Application
6.3.1 North America Specialty Pharmaceuticals Market Size by Application (2016-2021)
6.3.2 North America Specialty Pharmaceuticals Market Size by Application (2022-2027)
6.3.3 North America Specialty Pharmaceuticals Market Size by Application (2016-2027)
6.4 North America Specialty Pharmaceuticals Market Size by Country
6.4.1 North America Specialty Pharmaceuticals Market Size by Country (2016-2021)
6.4.2 North America Specialty Pharmaceuticals Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Specialty Pharmaceuticals Market Size (2016-2027)
7.2 Europe Specialty Pharmaceuticals Market Size by Type
7.2.1 Europe Specialty Pharmaceuticals Market Size by Type (2016-2021)
7.2.2 Europe Specialty Pharmaceuticals Market Size by Type (2022-2027)
7.2.3 Europe Specialty Pharmaceuticals Market Size by Type (2016-2027)
7.3 Europe Specialty Pharmaceuticals Market Size by Application
7.3.1 Europe Specialty Pharmaceuticals Market Size by Application (2016-2021)
7.3.2 Europe Specialty Pharmaceuticals Market Size by Application (2022-2027)
7.3.3 Europe Specialty Pharmaceuticals Market Size by Application (2016-2027)
7.4 Europe Specialty Pharmaceuticals Market Size by Country
7.4.1 Europe Specialty Pharmaceuticals Market Size by Country (2016-2021)
7.4.2 Europe Specialty Pharmaceuticals Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Specialty Pharmaceuticals Market Size (2016-2027)
8.2 Asia-Pacific Specialty Pharmaceuticals Market Size by Type
8.2.1 Asia-Pacific Specialty Pharmaceuticals Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Specialty Pharmaceuticals Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Specialty Pharmaceuticals Market Size by Type (2016-2027)
8.3 Asia-Pacific Specialty Pharmaceuticals Market Size by Application
8.3.1 Asia-Pacific Specialty Pharmaceuticals Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Specialty Pharmaceuticals Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Specialty Pharmaceuticals Market Size by Application (2016-2027)
8.4 Asia-Pacific Specialty Pharmaceuticals Market Size by Region
8.4.1 Asia-Pacific Specialty Pharmaceuticals Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Specialty Pharmaceuticals Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Specialty Pharmaceuticals Market Size (2016-2027)
9.2 Latin America Specialty Pharmaceuticals Market Size by Type
9.2.1 Latin America Specialty Pharmaceuticals Market Size by Type (2016-2021)
9.2.2 Latin America Specialty Pharmaceuticals Market Size by Type (2022-2027)
9.2.3 Latin America Specialty Pharmaceuticals Market Size by Type (2016-2027)
9.3 Latin America Specialty Pharmaceuticals Market Size by Application
9.3.1 Latin America Specialty Pharmaceuticals Market Size by Application (2016-2021)
9.3.2 Latin America Specialty Pharmaceuticals Market Size by Application (2022-2027)
9.3.3 Latin America Specialty Pharmaceuticals Market Size by Application (2016-2027)
9.4 Latin America Specialty Pharmaceuticals Market Size by Country
9.4.1 Latin America Specialty Pharmaceuticals Market Size by Country (2016-2021)
9.4.2 Latin America Specialty Pharmaceuticals Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Specialty Pharmaceuticals Market Size (2016-2027)
10.2 Middle East & Africa Specialty Pharmaceuticals Market Size by Type
10.2.1 Middle East & Africa Specialty Pharmaceuticals Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Specialty Pharmaceuticals Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Specialty Pharmaceuticals Market Size by Type (2016-2027)
10.3 Middle East & Africa Specialty Pharmaceuticals Market Size by Application
10.3.1 Middle East & Africa Specialty Pharmaceuticals Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Specialty Pharmaceuticals Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Specialty Pharmaceuticals Market Size by Application (2016-2027)
10.4 Middle East & Africa Specialty Pharmaceuticals Market Size by Country
10.4.1 Middle East & Africa Specialty Pharmaceuticals Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Specialty Pharmaceuticals Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Specialty Pharmaceuticals Introduction
11.1.4 Teva Pharmaceuticals Revenue in Specialty Pharmaceuticals Business (2016-2021)
11.1.5 Teva Pharmaceuticals Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Specialty Pharmaceuticals Introduction
11.2.4 Abbvie Revenue in Specialty Pharmaceuticals Business (2016-2021)
11.2.5 Abbvie Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Specialty Pharmaceuticals Introduction
11.3.4 Amgen Revenue in Specialty Pharmaceuticals Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Specialty Pharmaceuticals Introduction
11.4.4 Johnson & Johnson Revenue in Specialty Pharmaceuticals Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Specialty Pharmaceuticals Introduction
11.5.4 Celgene Revenue in Specialty Pharmaceuticals Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences Specialty Pharmaceuticals Introduction
11.6.4 Gilead Sciences Revenue in Specialty Pharmaceuticals Business (2016-2021)
11.6.5 Gilead Sciences Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Specialty Pharmaceuticals Introduction
11.7.4 Roche Revenue in Specialty Pharmaceuticals Business (2016-2021)
11.7.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Specialty Pharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Pharmaceuticals
Table 3. Key Players of Parenteral Pharmaceuticals
Table 4. Key Players of Transdermal Pharmaceuticals
Table 5. Global Specialty Pharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Specialty Pharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Specialty Pharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Specialty Pharmaceuticals Market Share by Regions (2016-2021)
Table 9. Global Specialty Pharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Specialty Pharmaceuticals Market Share by Regions (2022-2027)
Table 11. Specialty Pharmaceuticals Market Trends
Table 12. Specialty Pharmaceuticals Market Drivers
Table 13. Specialty Pharmaceuticals Market Challenges
Table 14. Specialty Pharmaceuticals Market Restraints
Table 15. Global Specialty Pharmaceuticals Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Specialty Pharmaceuticals Market Share by Players (2016-2021)
Table 17. Global Top Specialty Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Pharmaceuticals as of 2020)
Table 18. Ranking of Global Top Specialty Pharmaceuticals Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Specialty Pharmaceuticals Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Specialty Pharmaceuticals Product Solution and Service
Table 22. Date of Enter into Specialty Pharmaceuticals Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Specialty Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Specialty Pharmaceuticals Revenue Market Share by Type (2016-2021)
Table 26. Global Specialty Pharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Specialty Pharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Specialty Pharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Specialty Pharmaceuticals Revenue Market Share by Application (2016-2021)
Table 30. Global Specialty Pharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Specialty Pharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Specialty Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Specialty Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Specialty Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Specialty Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Specialty Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Specialty Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Specialty Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Specialty Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Specialty Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Specialty Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Specialty Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Specialty Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Specialty Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Specialty Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Specialty Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Specialty Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Specialty Pharmaceuticals Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Specialty Pharmaceuticals Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Specialty Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Specialty Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Specialty Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Specialty Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Specialty Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Specialty Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Specialty Pharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Specialty Pharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Specialty Pharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Specialty Pharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Specialty Pharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Specialty Pharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 62. Teva Pharmaceuticals Company Details
Table 63. Teva Pharmaceuticals Business Overview
Table 64. Teva Pharmaceuticals Specialty Pharmaceuticals Product
Table 65. Teva Pharmaceuticals Revenue in Specialty Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 66. Teva Pharmaceuticals Recent Development
Table 67. Abbvie Company Details
Table 68. Abbvie Business Overview
Table 69. Abbvie Specialty Pharmaceuticals Product
Table 70. Abbvie Revenue in Specialty Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 71. Abbvie Recent Development
Table 72. Amgen Company Details
Table 73. Amgen Business Overview
Table 74. Amgen Specialty Pharmaceuticals Product
Table 75. Amgen Revenue in Specialty Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Specialty Pharmaceuticals Product
Table 80. Johnson & Johnson Revenue in Specialty Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Celgene Company Details
Table 83. Celgene Business Overview
Table 84. Celgene Specialty Pharmaceuticals Product
Table 85. Celgene Revenue in Specialty Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 86. Celgene Recent Development
Table 87. Gilead Sciences Company Details
Table 88. Gilead Sciences Business Overview
Table 89. Gilead Sciences Specialty Pharmaceuticals Product
Table 90. Gilead Sciences Revenue in Specialty Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 91. Gilead Sciences Recent Development
Table 92. Roche Company Details
Table 93. Roche Business Overview
Table 94. Roche Specialty Pharmaceuticals Product
Table 95. Roche Revenue in Specialty Pharmaceuticals Business (2016-2021) & (US$ Million)
Table 96. Roche Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Pharmaceuticals Market Share by Type: 2020 VS 2027
Figure 2. Oral Pharmaceuticals Features
Figure 3. Parenteral Pharmaceuticals Features
Figure 4. Transdermal Pharmaceuticals Features
Figure 5. Global Specialty Pharmaceuticals Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Specialty Pharmacies Case Studies
Figure 9. Mail Order Case Studies
Figure 10. Specialty Pharmaceuticals Report Years Considered
Figure 11. Global Specialty Pharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Specialty Pharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Specialty Pharmaceuticals Market Share by Regions: 2020 VS 2027
Figure 14. Global Specialty Pharmaceuticals Market Share by Regions (2022-2027)
Figure 15. Global Specialty Pharmaceuticals Market Share by Players in 2020
Figure 16. Global Top Specialty Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Pharmaceuticals as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Specialty Pharmaceuticals Revenue in 2020
Figure 18. Global Specialty Pharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 19. Global Specialty Pharmaceuticals Revenue Market Share by Type (2022-2027)
Figure 20. North America Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Specialty Pharmaceuticals Market Share by Type (2016-2027)
Figure 22. North America Specialty Pharmaceuticals Market Share by Application (2016-2027)
Figure 23. North America Specialty Pharmaceuticals Market Share by Country (2016-2027)
Figure 24. United States Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Specialty Pharmaceuticals Market Share by Type (2016-2027)
Figure 28. Europe Specialty Pharmaceuticals Market Share by Application (2016-2027)
Figure 29. Europe Specialty Pharmaceuticals Market Share by Country (2016-2027)
Figure 30. Germany Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Specialty Pharmaceuticals Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Specialty Pharmaceuticals Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Specialty Pharmaceuticals Market Share by Region (2016-2027)
Figure 40. China Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Specialty Pharmaceuticals Market Share by Type (2016-2027)
Figure 48. Latin America Specialty Pharmaceuticals Market Share by Application (2016-2027)
Figure 49. Latin America Specialty Pharmaceuticals Market Share by Country (2016-2027)
Figure 50. Mexico Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Specialty Pharmaceuticals Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Specialty Pharmaceuticals Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Specialty Pharmaceuticals Market Share by Country (2016-2027)
Figure 56. Turkey Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Specialty Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Teva Pharmaceuticals Revenue Growth Rate in Specialty Pharmaceuticals Business (2016-2021)
Figure 60. Abbvie Revenue Growth Rate in Specialty Pharmaceuticals Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Specialty Pharmaceuticals Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Specialty Pharmaceuticals Business (2016-2021)
Figure 63. Celgene Revenue Growth Rate in Specialty Pharmaceuticals Business (2016-2021)
Figure 64. Gilead Sciences Revenue Growth Rate in Specialty Pharmaceuticals Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Specialty Pharmaceuticals Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed